zineryt pdr+solv for cut soln
astellas pharma co. ltd - erythromycin, zinc acetate - pdr+solv for cut soln - 40 mg/ml,1 micromol - antiinfectives for treatment of acne
difene 50 milligram capsules gastro-resistant
astellas pharma co. ltd - diclofenac sodium - capsules gastro-resistant - 50 milligram - acetic acid derivatives and related substances
difene 25 milligram capsules gastro-resistant
astellas pharma co. ltd - diclofenac sodium - capsules gastro-resistant - 25 milligram - acetic acid derivatives and related substances
difene 100 milligram capsules modified release
astellas pharma co. ltd - diclofenac sodium - capsules modified release - 100 milligram - acetic acid derivatives and related substances
difene dual release 75 milligram capsules modified release
astellas pharma co. ltd - diclofenac sodium - capsules modified release - 75 milligram - acetic acid derivatives and related substances
zepholin s.r. 200 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 200 milligram - xanthines
zepholin s.r. 100 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 100 milligram - xanthines
zepholin s.r. 350 milligram prolonged release capsules
astellas pharma co. ltd - theophylline - prolonged release capsules - 350 milligram - xanthines
difene ampoules 75/3 mg/ml solution injection or concentrate for solution infusion
astellas pharma co. ltd - diclofenac sodium - solution injection or concentrate for solution infusion - 75/3 mg/ml
protopic- tacrolimus ointment
astellas pharma us inc. - tacrolimus (unii: wm0haq4wnm) (tacrolimus anhydrous - unii:y5l2157c4j) - tacrolimus 0.3 mg in 1 g - protopic ointment, both 0.03% and 0.1% for adults, and only 0.03% for children aged 2 to 15 years, is indicated as second-line therapy for the short-term and non-continuous chronic treatment of moderate to severe atopic dermatitis in non-immunocompromised adults and children who have failed to respond adequately to other topical prescription treatments for atopic dermatitis, or when those treatments are not advisable. protopic ointment is not indicated for children younger than 2 years of age (see boxed warning, warnings and precautions: pediatric use). protopic (tacrolimus) ointment is contraindicated in patients with a history of hypersensitivity to tacrolimus or any other component of the ointment.